Showing results (11-20 of 136) with videos related to
Sort By:
Pageof 14
The Biochemical Journal|April 1, 1987
The effect of Ca2+, phospholipid and factor V on the anti-(factor Xa) activity of heparin and its high-affinity oligosaccharidesT W Barrowcliffe, S J Havercroft, G Kemball-Cook, et al.British Journal of Haematology|June 1, 1993
The behaviour of different factor VIII concentrates in a chromogenic factor X-activating systemG Kemball-Cook, J E Tubbs, N J Dawson, et al.Biochimica Et Biophysica Acta|May 29, 1998
Structural determination of lipid-bound human blood coagulation factor IXS Stoylova, E Gray, T W Barrowcliffe, et al.Thrombosis and Haemostasis|December 22, 1988
Factor VIII procoagulant protein interacts with phospholipid vesicles via its 80 kDa light chainG Kemball-Cook, S J Edwards, K Sewerin, et al.British Journal of Haematology|April 1, 1979
Anticoagulant activities of high and low molecular weight heparin fractionsT W Barrowcliffe, E A Johnson, C A Eggleton, et al.Thrombosis and Haemostasis|April 1, 1995
Measurement of activated factor IX in factor IX concentrates: correlation with in vivo thrombogenicityE Gray, J Tubbs, S Thomas, et al.The Journal of Laboratory and Clinical Medicine|March 1, 1981
Factor VIII-related activities in therapeutic concentratesT W Barrowcliffe, G Kemball-Cook, G Morris, et al.Nucleic Acids Research|January 1, 1997
The Factor VIII Mutation Database on the World Wide Web: the haemophilia A mutation, search, test and resource site. HAMSTeRS update (version 3.0)G Kemball-Cook, E G TuddenhamThrombosis and Haemostasis|November 3, 1998
Modification of factor VIII in therapeutic concentrates after virus inactivation by solvent-detergent and pasteurisationS Raut, M Di Giambattista, S A Bevan, et al.Developments in Biological Standardization|January 1, 1993
Viral inactivation vs biological activityT W BarrowcliffePageof 14